Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders Equity

v3.22.1
Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Common Shares Issuable [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2019 $ 1 $ 74     $ 461,874 $ (436,234) $ 46,317 $ 72,532
Balance (in shares) at Dec. 31, 2019 1,341,167 74,027,425 500,000          
Stock-based compensation expense         13,451     13,451
Issuance of common stock related to equity plans   $ 2     16     18
Issuance of common stock related to equity plans (in shares)   2,335,808            
Issuance of common stock under ESPP         253     253
Issuance of common stock under ESPP (in shares)   122,786            
Issuance of common stock for at-the-market offering, net   $ 18     45,809     45,827
Issuance of common stock for at-the-market offering, net (in shares)   17,409,257            
Preferred A dividends declared and paid         (6,515)     (6,515)
Repurchase of Series A preferred stock, net       $ (70) (2)     (72)
Repurchase of Series A preferred stock (in shares) (5,000)              
Retirement of Series A preferred stock       $ 70 (70)      
Issuance of Series A preferred stock for cash, net $ 2       35,541     35,543
Issuance of Series A preferred stock for cash, net (in shares) 2,090,971              
Partner company's offering, net         53,749     53,749
Partner company's at-the-market offering, net         70,988     70,988
Partner company's preferred stock offering, net         7,074     7,074
Issuance of common stock under partner company's ESPP         349     349
Partner company's dividends declared and paid         (237)     (237)
Partner company's exercise of warrants for cash         13     13
Partner company's exercise of options for cash         13     13
Reclass partner company's warrants from liability to equity         1,216     1,216
Issuance of partner company's common shares for research and development expenses         46     46
Common shares issued for 2017 Subordinated Note Financing interest expense   $ 1     1,816     1,317
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   982,216 (500,000)          
Issuance of warrants in conjunction with Oaktree Note         4,419     4,419
Non-controlling interest in subsidiaries/partner companies         (106,803)   106,803  
Net loss attributable to non-controlling interest             (56,459) (56,459)
Net loss attributable to common stockholders           (46,526)   (46,526)
Balance at Dec. 31, 2020 $ 3 $ 95     583,000 (482,760) 96,661 196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492            
Stock-based compensation expense         19,486     19,486
Issuance of common stock related to equity plans   $ 3     (3)      
Issuance of common stock related to equity plans (in shares)   3,119,324            
Issuance of common stock under ESPP         278     278
Issuance of common stock under ESPP (in shares)   117,428            
Issuance of common stock for at-the-market offering, net   $ 3     9,082     9,085
Issuance of common stock for at-the-market offering, net (in shares)   3,067,446            
Preferred A dividends declared and paid         (8,031)     (8,031)
Partner company's offering, net         (34,996)     (34,996)
Partner company's at-the-market offering, net         (110,887)     (110,887)
Issuance of common stock under partner company's ESPP         309     309
Partner company's dividends declared and paid         (749)     (749)
Partner company's exercise of options for cash         7     7
Issuance of partner company's common shares for research and development expenses         176     176
Common shares issued for dividend on partner company's convertible preferred shares         820     820
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   253,815            
Conversion of partner company convertible preferred shares         21,812     21,812
Conversion of partner company derivative warrant liabilities         4,628     4,628
Non-controlling interest in subsidiaries/partner companies         (120,665)   120,665  
Net loss attributable to non-controlling interest             (100,123) (100,123)
Net loss attributable to common stockholders           (64,703)   (64,703)
Balance at Dec. 31, 2021 $ 3 $ 101     $ 656,033 $ (547,463) $ 117,203 $ 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 101,435,505